COMP <GO>
CBIO vs GYRE // FORWARD P/E MULTIPLE
Crescent Biopharma Inc. (NASDAQ) VS. Gyre Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CBIO 1
— GYRE 7
■ METRIC PARITY
LAST: $12.91 (-4.23%) • MKT CAP: $500.7M
forward-pe
—
LAST: $4.73 (+3.84%) • MKT CAP: $507.9M
forward-pe
67.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBIO VS. GYRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBIO | GYRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 95.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.40% | -60.40 | GYRE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 53.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.86% | -0.03% | -13.83 | GYRE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 9.90% | -69.90 | GYRE | /operating-margins <GO> |
| Net Profit Margin | 1.40% | 8.50% | -7.10 | GYRE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 10.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.36 | 14.33 | -7.97 | GYRE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | GYRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 38.0 | +8.50 | CBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 67.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $500.7M | $507.9M | -$7.2M | GYRE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBIO REV | GYRE REV | CBIO GROSS % | GYRE GROSS % | CBIO FCF | GYRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.8M | $116.6M | — | 95.4% | -$72.5M | -$180.0K |
| FY 2024 | $112.1M | $105.8M | — | 96.3% | -$31.1M | -$6.0M |
| FY 2023 | $110.0M | $113.5M | — | — | -$34.9M | $25.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBIO // BETA —
GYRE // BETA —